KYOWA: Improving Lives with Health Science
KYOWA HAKKO USA, INC. is the North American sales office for KYOWA HAKKO BIO CO., LTD., and distributor for Kyowa Pharma Chemical Co. As an international health ingredients manufacturer and a world leader in the development, manufacturing and marketing of nutraceuticals, pharmaceuticals and food products, Kyowa is a pioneer in the development and application of fermentation technology and maintains an ongoing commitment to research, developing innovative new products and quality management.
Kyowa is the maker of branded ingredients including Setria® Glutathione, IMMUSE™ Lactococcus lactis strain Plasma, Cognizin® Citicoline, Pantesin® Pantethine, VELOX® Patented Performance Blend, and EYEMUSE™ Lacticaseibacillus paracasei KW3110.
August 8, 2022
The Tap Challenge App is finally here for professional button mashers or anyone who wants to challenge themselves each day! View news »
Manufacturing strain of Kyowa Hakko Bio’s 2'-fucosyllactose, a human milk oligosaccharide (HMO), passed safety evaluation in ChinaJune 23, 2022
KYOWA HAKKO BIO CO., LTD. (Kyowa Hakko Bio) is pleased to announce that its manufacturing strain used for producing 2'-fucosyllactose (2’-FL), the most abundant HMO in human milk, has passed the safety evaluation by the Chinese Ministry of Agriculture and Rural Affairs (MARA), while other manufacturing strains used for producing 3'-sialyllactose (3'-SL) and 6'-sialyllactose (6'-SL) are currently under review. View news »